SCHEMBL2965446

SCHEMBL2965446

CNC(=O)CC(NC(=O)O)C1CCN(CCc2cc(-c3ccc(Cl)cc3)on2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
POLB P06746 3/20 0.42
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
NOTUM Q6P988 1/20 0.39
DRD4 P21917 3/20 0.39
DRD3 P35462 3/20 0.39
DRD2 P14416 2/20 0.39
CYP1A2 P05177 3/20 0.38
CYP2D6 P10635 2/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PRCP P42785 3/20 0.38
CYP3A4 P08684 2/20 0.38
TSHR P16473 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
F10 P00742 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2981428 0.96 MAPT (0.43) MAPTPOLBNPC1RAB9ANOTUM
SCHEMBL2981404 0.85 LMNA (0.42) MAPTPOLBNOTUMDRD4DRD3
SCHEMBL2976745 0.82 JAK2 (0.42) POLBDRD4DRD3DRD2ALDH1A1
SCHEMBL2975024 0.81 ARG1 (0.44) MAPTPRCPALDH1A1F10
SCHEMBL2972014 0.80 DRD2 (0.44) MAPTPOLBRAB9ANOTUMDRD4
SCHEMBL2967606 0.78 HDAC3 (0.39) MAPTNPC1RAB9ANOTUMCYP1A2
SCHEMBL2965450 0.78 NPC1 (0.39) MAPTPOLBNPC1RAB9ANOTUM
SCHEMBL5709515 0.77 CYP1A2 (0.45) MAPTPOLBNPC1RAB9ANOTUM
SCHEMBL2979862 0.77 SIGMAR1 (0.44)
SCHEMBL2970163 0.77 SIGMAR1 (0.49) POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781590-B2 Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors SANOFI-AVENTIS (FR) 2010-08-24 US disclosed
US-20070021403-A1 PIPERIDINYLALKYLCARBAMATE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THE THERAPEUTIC USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021403-A1 PIPERIDINYLALKYLCARBAMATE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THE THERAPEUTIC USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS FAAH, FAAH2, CNR2 MAPT 4642/4885POLB 2201/4885NPC1 558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.